Philip D Charles, MD
Disclosures: Consulting Fee-There isn’t an FDA drug approved yet. This is a study of a new biologic to see if it is safe and effective. -Revance-N/A|Consulting Fee-There isn’t an FDA drug approved yet. This is a study of a new biologic to see if it is safe and effective. -Neuroderm-N/A|Consulting Fee-Dysport-Ipsen-Not likely|Contracted Research-There isn’t an FDA drug approved yet. This is a study of a new biologic to see if it is safe and effective. -Allergan-N/A|Contracted Research-There isn’t an FDA drug approved yet. This is a study of a new biologic to see if it is safe and effective. -Voyager-N/A|Contracted Research-There isn’t an FDA drug approved yet. This is a study of a new biologic to see if it is safe and effective. -Intec-N/A|Contracted Research-There isn’t an FDA drug approved yet. This is a study of a new biologic to see if it is safe and effective. -Pharma Two B-N/A
No Bio Available.